Financiere de Tubize (CHIX:TUBB) Forward PE Ratio: 0.00 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:TUBB Financiere de Tubize SA CHIX:TUBB
42 GF Score
Price €235.20
! 1 Warning Sign
View Full Analysis

What is Financiere de Tubize Forward PE Ratio?

Financiere de Tubize CHIX:TUBB 42 Forward PE Ratio is 0.00 as of Jul. 27, 2026. GuruFocus rates CHIX:TUBB with a GF Score™ of 42/100. The stock has 1 warning sign investors should review. Among 353 Biotechnology companies, Financiere de Tubize ranks worse than 283285.84% on this metric.

Financiere de Tubize's Forward PE Ratio for today is 0.00.

Financiere de Tubize's PE Ratio without NRI for today is 100.19.

Financiere de Tubize's PE Ratio (TTM) for today is 100.19.


Financiere de Tubize  (CHIX:TUBb) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Financiere de Tubize Forward PE Ratio Related Terms


Financiere de Tubize Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize Forward PE Ratio Chart

Financiere de Tubize Annual Data
Trend
Forward PE Ratio

Financiere de Tubize Semi-Annual Data
Forward PE Ratio

CHIX:TUBB vs VRTX, REGN, RVMD: Forward PE Ratio Comparison

For the Biotechnology subindustry, Financiere de Tubize's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Financiere de Tubize Forward PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's Forward PE Ratio falls into.


CHIX:TUBB
42GF Score
Financiere de Tubize SA CHIX:TUBB
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Financiere de Tubize (CHIX:TUBB) has a Forward PE Ratio of 0.00 as of Jul. 27, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Financiere de Tubize and its competitors. According to the industry distribution chart, Financiere de Tubize ranks #999999 out of 353 companies in the Biotechnology industry.
Is Financiere de Tubize's Forward PE Ratio too high?
Financiere de Tubize's current Forward PE Ratio is 0.00. Based on the distribution chart, Financiere de Tubize ranks #999999 out of 353 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Financiere de Tubize has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's Forward PE Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Financiere de Tubize ranks #999999 out of 353 companies for Forward PE Ratio. This places Financiere de Tubize in the lower half of its industry. The industry median Forward PE Ratio is 22.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 22.00, based on 353 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Financiere de Tubize and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 22.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Financiere de Tubize's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (CHIX:TUBB) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Financiere de Tubize's overall GF Score™ is 42/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Financiere de Tubize (CHIX:TUBB), the current Forward PE Ratio is 0.00 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
42GF Score

Get the complete analysis for CHIX:TUBB

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€235.20
Price